Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finke

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Mayo Clinic Proceedings|January 4, 2012
One thousand patients with primary myelofibrosis: the mayo clinic experienceAyalew Tefferi, Terra L Lasho, Thitina Jimma, et al.
Cancer|April 19, 2007
Clinical correlates of JAK2V617F allele burden in essential thrombocythemiaJaya Kittur, Ryan A Knudson, Terra L Lasho, et al.
Zeitschrift Fur Medizinische Physik|July 22, 2022
Ultrahigh resolution whole body photon counting computed tomography as a novel versatile tool for translational research from mouse to manEckhard Wehrse, Laura Klein, Lukas Thomas Rotkopf, et al.
Blood Cancer Journal|January 27, 2019
Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive modelRangit R Vallapureddy, Mythri Mudireddy, Domenico Penna, et al.
Leukemia|March 6, 2009
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlatesA Tefferi, R L Levine, K-H Lim, et al.
Blood Cancer Journal|April 28, 2021
Mutations and thrombosis in essential thrombocythemiaPaola Guglielmelli, Naseema Gangat, Giacomo Coltro, et al.
Blood Cancer Journal|January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.
Leukemia Research|October 22, 2008
Oligonucleotide array CGH studies in myeloproliferative neoplasms: comparison with JAK2V617F mutational status and conventional chromosome analysisAyalew Tefferi, Shireen Sirhan, Yi Sun, et al.
Blood Cancer Journal|February 14, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.
The New England Journal of Medicine|September 3, 2015
A Pilot Study of the Telomerase Inhibitor Imetelstat for MyelofibrosisAyalew Tefferi, Terra L Lasho, Kebede H Begna, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Mayo Clinic Proceedings|January 4, 2012
One thousand patients with primary myelofibrosis: the mayo clinic experienceAyalew Tefferi, Terra L Lasho, Thitina Jimma, et al.
Cancer|April 19, 2007
Clinical correlates of JAK2V617F allele burden in essential thrombocythemiaJaya Kittur, Ryan A Knudson, Terra L Lasho, et al.
Zeitschrift Fur Medizinische Physik|July 22, 2022
Ultrahigh resolution whole body photon counting computed tomography as a novel versatile tool for translational research from mouse to manEckhard Wehrse, Laura Klein, Lukas Thomas Rotkopf, et al.
Blood Cancer Journal|January 27, 2019
Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive modelRangit R Vallapureddy, Mythri Mudireddy, Domenico Penna, et al.
Leukemia|March 6, 2009
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlatesA Tefferi, R L Levine, K-H Lim, et al.
Blood Cancer Journal|April 28, 2021
Mutations and thrombosis in essential thrombocythemiaPaola Guglielmelli, Naseema Gangat, Giacomo Coltro, et al.
Blood Cancer Journal|January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.
Leukemia Research|October 22, 2008
Oligonucleotide array CGH studies in myeloproliferative neoplasms: comparison with JAK2V617F mutational status and conventional chromosome analysisAyalew Tefferi, Shireen Sirhan, Yi Sun, et al.
Blood Cancer Journal|February 14, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.
The New England Journal of Medicine|September 3, 2015
A Pilot Study of the Telomerase Inhibitor Imetelstat for MyelofibrosisAyalew Tefferi, Terra L Lasho, Kebede H Begna, et al.
Pageof 18